Skip to main content
Midas Edge

PMGC Holdings Inc.

For the period ended Mar 31, 2026. Filed May 15, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 15, 2026

ELAB$1.58-1.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

EXHIBIT INDEX

Exhibit No.Description
3.1Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's registration statement on Form S-1 filed with the SEC on February 12, 2025).
3.2Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company's registration statement on Form S-1 filed with the SEC on February 12, 2025).
3.3Certificate of Designations, Rights, and Preferences of Series B Preferred Stock (incorporated by reference to Exhibit 3.3 to the Company’s registration statement on Form S-1 filed with the SEC on February 12, 2025).
3.4Amended and Restated Certificate of Designations, Rights, and Preferences of Series B Preferred Stock (incorporated by reference to Exhibit 3.1 in the Form 8-K filed with the SEC on February 21, 2025).
3.5Certificate of Amendment to Articles of Incorporation (incorporated by reference to Exhibit 3.1 in the Form 8-K filed with the SEC on March 6, 2025).
3.6Certificate of Amendment filed on August 28, 2025 (included as Exhibit 3.1 in the Form 8-K filed with the SEC on September 4, 2025 and incorporated herein by reference).
3.7Certificate of Amendment filed on September 15, 2025 (included as Exhibit 3.1 in the Form 8-K filed with the SEC on September 17, 2025 and incorporated herein by reference).
3.8Certificate of Amendment filed on January 6, 2026 (included as Exhibit 3.1 in the Form 8-K filed with the SEC on January 6, 2026 and incorporated herein by reference).
3.9Certificate of Amendment filed on March 4, 2026 (included as Exhibit 3.1 in the Form 8-K filed with the SEC on March 10, 2026 and incorporated herein by reference).
10.1Form of Pre-Paid Purchase # 2 (incorporated by reference to the Exhibit 10.1 in the Form 8-K filed with the SEC on January 12, 2026).
10.2Form of Pre-Paid Purchase # 3 (incorporated by reference to Exhibit 10.1 in the Form 8-K filed with the SEC on January 20, 2026).
10.3*+Stock Purchase Agreement dated February 2, 2026, by and between the Company, SVM Machining, Inc., and selling stockholder of SVM Machining, Inc. dated as of February 2, 2026 (included as Exhibit 10.1 in the Form 8-K filed with the SEC on February 6, 2026).
10.4+License Agreement between Northstrive Biosciences Inc. and Modulant Biosciences LLC dated February 4, 2026 (incorporated by reference to the Exhibit 10.1 in the Form 8-K filed with the SEC on February 10, 2026).
10.5Form of Pre-Paid Purchase # 4 (incorporated by reference to Exhibit 10.1 in the Form 8-K filed with the SEC on March 3, 2026).
10.4+Third Amendment to License Agreement between Northstrive Biosciences Inc. and MOA Life Plus Co., Ltd (incorporated by reference to Exhibit 10.1 in the Form 8-K filed with the SEC on March 27, 2026).
31.1Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSInline XBRL Instance Document.
101.SCHInline XBRL Schema Document.
101.CALInline XBRL Calculation Linkbase Document.
101.DEFInline XBRL Definition Linkbase Document.
101.LABInline XBRL Label Linkbase Document.
101.PREInline XBRL Presentation Linkbase Document.
104Cover Page Interactive Data File (embedded within the Inline XBRL document filed as Exhibit 101).
#Management contract or compensatory plan.
*The schedules, exhibits or similar attachments have been omitted from this filing pursuant to Item 601(b)(2) of Regulation S-K. The Company will furnish copies of any schedules, exhibits, or similar attachments to the SEC upon request. Certain portions of this exhibit have been redacted.
+Portions of this exhibit have been redacted.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.